Der DOW JONES gewinnt heute 99,49 Zähler oder 1,25% auf 8089,05 Punkte
Die Hightechs des Nasdaq Composite gewinnen 16,92 Zähler oder 1,28% auf 1342,19 Punkte.
Meistgehandelte Aktie
Der NASDAQ 100 gewinnt 15,01 Zähler oder 1,52% auf 1001,42Punkte
besser zeigte sich der Amex Interactiv Internet Index (IIX) , er gewinnt aktuell 1,58 Zähler bzw 1,84 Prozent auf 87,23 Punkte .
Der PHLX Semiconductor Sector (SOX) gewinnt 2,38 Zähler oder 0,85% auf 282,03Punkte
Der Amex Biotech Index (BTK) gewinnt 1,25 Zähler bzw. 0,37% auf 339,61Punkte
Der S&P 500 (SPX) gewinnt 10,98 Zähler oder 1,30% auf 858,46Punkte
***
EU/$ >> 1,082 ***
AFTER THE CLOSE
Coherent beats by $0.04 (COHR) 17.37: Reports Q1 (Dec) earnings of $0.10 per share, ex items,
$0.04 better than the Multex consensus of $0.06; revenues rose 5.6% year/year to $102.0 mln vs the $96.6 mln consensus.
CYTYC Corp tops estimates (CYTC) 10.80 +0.17: Reports Q4 (Dec) earnings of $0.15 per share,
$0.02 better than the Multex consensus of $0.13; revenues rose 5.4% year/year to $66.7 mln vs the $64.3 mln consensus.
Interwoven tops estimates (IWOV) 2.87 +0.05: Reports Q4 (Dec) loss of $0.03 per share, $0.03 better than the Multex consensus of ($0.06); revenues fell 30.1% year/year to $31.1 mln vs the $30.3 mln consensus.
.
RealNetworks beats by a penny, issues guidance (RNWK) 3.31 +0.08: Reports Q4 (Dec) pro forma loss of $0.01 per share, $0.01 better than the Multex consensus of ($0.02); revenues rose 1.8% year/year to $46.2 mln vs the $45.1 mln consensus. Expects Q1 GAAP loss of $0.02-$0.04, although it is unclear if this is comparable to the Multex consensus of ($0.01).
Cognex tops estimates; updates guidance (CGNX) 18.60 -0.07: Reports Q4 (Dec) earnings of $0.04 per share, $0.02 better than the Multex consensus of $0.02; revenues rose 34.1% year/year to $33.8 mln vs the $32.4 mln consensus; expects revenue for the first quarter of 2003 to decline on a sequential basis to between $31 million and $33 million -- Multex consensus estimate is for revs of $32.3 mln.
Akamai Tech beats by $0.01 (AKAM) 1.36 +0.05: Reports Q4 (Dec) loss of $0.24 per share, $0.01 better than the Multex consensus of ($0.25); revenues fell 4.6% year/year to $35.4 mln vs the $32.4 mln consensus.
.
Millennium Pharm beats by 4 cents, issues 2003 rev guidance (MLNM) 8.36 +0.35: Reports Q4 (Dec) loss of $0.23 per share,
$0.04 better than the Multex consensus of ($0.27); revenues rose 77.3% year/year to $96.8 mln vs the $103.8 mln consensus. Expects 2003 pro forma net loss of $290-$320 mln on $450-$475 mln in revs (rev consensus is $450.5 mln).
Novellus matches estimates (NVLS) 29.71 -0.28: Reports Q4 (Dec) earnings of $0.11 per share,
in line with the Multex consensus of $0.11; revenues fell 5.6% year/year to $217.6 mln vs the $211.6 mln consensus; deferred revenue at the end of the fourth quarter of 2002 was $130.1 million, a decrease of $26.6 million or 17.0 percent from $156.7 million at the end of the third quarter of 2002.
Veritas Software beats by $0.04 (VRTS) 18.70 +0.63: Reports Q4 (Dec) earnings of $0.18 per share,
$0.04 better than the Multex consensus of $0.14; revenues rose 8.3% year/year to $405.0 mln vs the $378.5 mln consensus.
weitere unter nachbörsliche quartalsberichte
----------------------------------
Nachbörsliche WINNER+LOSER:
Regulärer Handel +After Hours- Top 100
____________________________________________
Nasdaq 100 Future
Nasdaq 100 After Hours Indicator

_____________________________________________
_____________________________________________
KURSLISTE in €
DAX ------------------------------
NEMAX 50

DOW JONES 30 ------------
NASDAQ 100
US-STOCKS -------------------
MDAX

--------------------------------------------------------------
NACHBÖRSLICHE QUARTALSBERICHTE
EARNINGS KALENDER
WIRTSCHAFTSDATEN -VORSCHAU
FED- KALENDER
UP- and DOWNGRADES